Responses
Regular and Young Investigator Award Abstracts
Clinical Trials Completed
614 Microbiome modification with fecal microbiota transplant from healthy donors before anti-PD1 therapy reduces primary resistance to immunotherapy in advanced and metastatic melanoma patients
Compose a Response to This Article
Other responses
No responses have been published for this article.